145 related articles for article (PubMed ID: 31715099)
1. Enzymatic Preparation of 2'-5',3'-5'-Cyclic Dinucleotides, Their Binding Properties to Stimulator of Interferon Genes Adaptor Protein, and Structure/Activity Correlations.
Novotná B; Vaneková L; Zavřel M; Buděšínský M; Dejmek M; Smola M; Gutten O; Tehrani ZA; Pimková Polidarová M; Brázdová A; Liboska R; Štěpánek I; Vavřina Z; Jandušík T; Nencka R; Rulíšek L; Bouřa E; Brynda J; Páv O; Birkuš G
J Med Chem; 2019 Dec; 62(23):10676-10690. PubMed ID: 31715099
[TBL] [Abstract][Full Text] [Related]
2. Detection of Cyclic Dinucleotides by STING.
Du XX; Su XD
Methods Mol Biol; 2017; 1657():59-69. PubMed ID: 28889286
[TBL] [Abstract][Full Text] [Related]
3. Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential.
Dejmek M; Šála M; Brazdova A; Vanekova L; Smola M; Klíma M; Břehová P; Buděšínský M; Dračínský M; Procházková E; Zavřel M; Šimák O; Páv O; Boura E; Birkuš G; Nencka R
Structure; 2022 Aug; 30(8):1146-1156.e11. PubMed ID: 35690061
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic Synthesis of 3'-5', 3'-5' Cyclic Dinucleotides, Their Binding Properties to the Stimulator of Interferon Genes Adaptor Protein, and Structure/Activity Correlations.
Novotná B; Holá L; Staś M; Gutten O; Smola M; Zavřel M; Vavřina Z; Buděšínský M; Liboska R; Chevrier F; Dobiaš J; Boura E; Rulíšek L; Birkuš G
Biochemistry; 2021 Dec; 60(48):3714-3727. PubMed ID: 34788017
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biochemical and Biological Evaluation of Novel 7-Deazapurine Cyclic Dinucleotide Analogues as STING Receptor Agonists.
Vavřina Z; Perlíková P; Milisavljević N; Chevrier F; Smola M; Smith J; Dejmek M; Havlíček V; Buděšínský M; Liboska R; Vaneková L; Brynda J; Boura E; Řezáčová P; Hocek M; Birkuš G
J Med Chem; 2022 Oct; 65(20):14082-14103. PubMed ID: 36201304
[TBL] [Abstract][Full Text] [Related]
6. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
[TBL] [Abstract][Full Text] [Related]
7. 2',3'-Cyclic GMP-AMP Dinucleotides for STING-Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis.
Shang M; Lu K; Guan W; Cao S; Ren M; Zhou C
ChemMedChem; 2022 Jan; 17(2):e202100671. PubMed ID: 34807508
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING).
Xie X; Liu J; Wang X
Molecules; 2020 Nov; 25(22):. PubMed ID: 33198423
[TBL] [Abstract][Full Text] [Related]
9. Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
Frémond ML; Uggenti C; Van Eyck L; Melki I; Bondet V; Kitabayashi N; Hertel C; Hayday A; Neven B; Rose Y; Duffy D; Crow YJ; Rodero MP
Arthritis Rheumatol; 2017 Jul; 69(7):1495-1501. PubMed ID: 28426911
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of STING binding with and phosphorylation by TBK1.
Zhang C; Shang G; Gui X; Zhang X; Bai XC; Chen ZJ
Nature; 2019 Mar; 567(7748):394-398. PubMed ID: 30842653
[TBL] [Abstract][Full Text] [Related]
11. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
[TBL] [Abstract][Full Text] [Related]
12. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling.
Konno H; Konno K; Barber GN
Cell; 2013 Oct; 155(3):688-98. PubMed ID: 24119841
[TBL] [Abstract][Full Text] [Related]
13. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
[TBL] [Abstract][Full Text] [Related]
14. No magnesium is needed for binding of the stimulator of interferon genes to cyclic dinucleotides.
Smola M; Birkus G; Boura E
Acta Crystallogr F Struct Biol Commun; 2019 Sep; 75(Pt 9):593-598. PubMed ID: 31475926
[TBL] [Abstract][Full Text] [Related]
15. Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy.
Dejmek M; Brazdova A; Otava T; Polidarova MP; Klíma M; Smola M; Vavrina Z; Buděšínský M; Dračínský M; Liboska R; Boura E; Birkuš G; Nencka R
Eur J Med Chem; 2023 Nov; 259():115685. PubMed ID: 37567057
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of porcine STING
Cong X; Yuan Z; Du Y; Wu B; Lu D; Wu X; Zhang Y; Li F; Wei B; Li J; Wu J; Xu S; Wang J; Qi J; Shang G; Gu L
J Biol Chem; 2019 Jul; 294(30):11420-11432. PubMed ID: 31167783
[TBL] [Abstract][Full Text] [Related]
17. Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway.
Ding C; Song Z; Shen A; Chen T; Zhang A
Acta Pharm Sin B; 2020 Dec; 10(12):2272-2298. PubMed ID: 33354501
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides.
Yi G; Brendel VP; Shu C; Li P; Palanathan S; Cheng Kao C
PLoS One; 2013; 8(10):e77846. PubMed ID: 24204993
[TBL] [Abstract][Full Text] [Related]
19. Chemical synthesis, purification, and characterization of 3'-5'-linked canonical cyclic dinucleotides (CDNs).
Wang C; Hao M; Qi Q; Chen Y; Hartig JS
Methods Enzymol; 2019; 625():41-59. PubMed ID: 31455536
[TBL] [Abstract][Full Text] [Related]
20. The structural basis for the sensing and binding of cyclic di-GMP by STING.
Huang YH; Liu XY; Du XX; Jiang ZF; Su XD
Nat Struct Mol Biol; 2012 Jun; 19(7):728-30. PubMed ID: 22728659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
